Public stakeholder meeting on the approval and roll-out of COVID-19 vaccines in the EU

• Date:
  Friday, 08 January 2021, 13:00 (CET) - 15:15 (CET)
• Location:
  Online
  European Medicines Agency, Amsterdam, the Netherlands
• Twitter:
  Public stakeholder meeting on the approval and roll-out of COVID-19 vaccines in the EU

Event summary

EMA is organising this open event to:

• explain the basis for the approval and use of the new COVID-19 vaccines and how the safety of the vaccines will be assured;
• provide information on the roles of the European Commission and national public health authorities in the roll-out of the vaccines;
• listen to the needs, expectations and any concerns of the public and stakeholders.

Documents

Draft agenda - EMA public stakeholder meeting on the approval and roll-out of COVID-19 vaccines in the EU

Draft

List of attendees - EMA public stakeholder meeting on the approval and roll-out of COVID-19 vaccines in the EU

Presentation - Basis for the EU approval of new vaccines (H.Enzmann, CHMP)

Presentation - How the safety of the new COVID-19 vaccines will be monitored (S.Straus, PRAC)

Presentation - The European Commission’s role in the authorisation process and facilitation of roll-out vaccination (J.F. Ryan, DG SANTE)

Presentation - Ongoing actions for vaccine roll out at national level - Denmark as a case (N.Brun, HMA)

Video recordings

Full video recording

Basis for the EU approval of new vaccines (Presentation by Harald Enzmann, Head of Biological Health Threats and Vaccines Strategy)

How the safety of the new COVID-19 vaccines will be assured (Presentation by Sabine Straus, PRAC chair)

European Commission's role in the authorisation process and facilitation of roll out vaccination (Presentation by John F. Ryan, European Commission)

HMA - Ongoing actions for roll-out vaccination at national level (Presentation by Nikolai Brun, Head of Danish Medicines Agency)